Related content

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

By Zhu Xiaodong   Leaw Jiin   Gu Weilie   Qian Yiying   Du Hongyu   Wang Biyun   Hong Xiaonan   Yin Jiliang  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 929-936

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of N-(phosphonacetyl)-l-aspartate (PALA), 5-Fluorouracil and Recombinant Interferon- -2b in Patients with Advanced Gastric Carcinoma

By Wadler S.   Gleissner B.   Hilgenfeld R.U.   Thiel E.   Haynes H.   Kaleya R.   Rozenblit A.   Kreuser E.-D.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1254-1256

Elsevier

Access to resources Recommend Favorite

Clinical Benefit with Cisplatin, Hydroxyurea and 5-Fluorouracil/Leucovorin in Advanced Pancreatic Adenocarcinoma

By Raymond E.   de Gramont A.   Louvet C.   Tournigand C.   Demuynck B.   Beerblock K.   Carola E.   Krulik M.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 696-697

Elsevier

Access to resources Recommend Favorite

A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer

By Nishikawa Kazuhiro   Morita Satoshi   Matsui Takanori   Kobayashi Michiya   Takeuchi Yoji   Takahashi Ikuo   Sato Seiji   Miyashita Yumi   Tsuburaya Akira   Sakamoto Junichi   Kakeji Yoshihiro   Baba Hideo  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 363-369

Springer Publishing Company

Access to resources Recommend Favorite